Scott Gottlieb, who served as US Food and Drug Administration commissioner during the first half of President Trump’s first term, advised the pharmaceutical industry to seek a legislative extension of the user fee program because he sees “nothing good” coming from negotiating new agreements in the “current political environment.”
User Fees: Industry Should Push For Extension Of Current Agreement In Reconciliation Bill, Gottlieb Says
Trump’s former FDA commissioner sees ‘nothing good’ coming from negotiating a new user fee agreement in the ‘current political environment.’
